NCCH2006/MK010 Trial (FORTUNE Trial)
NCT04962867
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
75
Enrollment
OTHER_GOV
Sponsor class
Conditions
Advanced or Recurrent Solid Tumors
FGFR Gene Alterations
Interventions
DRUG:
E7090
Sponsor
National Cancer Center, Japan
Collaborators
[object Object]